Posted on 1/10/17
2 Reasons Pfizer's Stock Beat the Field in 2016
What happenedAccording to data from S&P Global Market Intelligence , Pfizer's (NYSE:PFE) shares gained 1.66% in 2016. While such a modest gain may not seem impressive . . .
Posted on 1/10/17
Is Celgene Simply the Best Biotech Stock on the Planet?
A mic drop at the end of Celgene (NASDAQ:CELG) CEO Mark Alles' presentation at the 35th Annual J.P. Morgan (NYSE: JPM) Healthcare Conference might have been . . .
Posted on 1/10/17
Sanofi and ImmuNext Enter into Agreement to Develop Treatments for Autoimmune Diseases
Sanofi and ImmuNext, Inc., announced today an agreement focused on the development of a novel antibody with the potential to treat a range of autoimmune diseases . . .
Posted on 1/10/17
Aridis Pharmaceuticals Receives Award from the Cystic Fibrosis Foundation Therapeutics to Advance Panaecin
Aridis Pharmaceuticals, Inc., a biopharmaceutical company applying proprietary technologies to produce novel anti-infectives and immunotherapies for infectious diseases, announced today it has secured a therapeutics development . . .
Posted on 1/9/17
Advaxis Provides 2017 Business Outlook
PRINCETON, N.J., Jan. 09, 2017 (GLOBE NEWSWIRE) -- Advaxis, Inc. (NASDAQ:ADXS), a clinical-stage biotechnology company developing cancer immunotherapies, today issued its 2017 business outlook to provide . . .
Posted on 1/9/17
Better Buy: Regeneron Pharmaceuticals, Inc. vs. Pfizer
Last year a handful of setbacks led shares of Regeneron Pharmaceuticals(NASDAQ:REGN) about 29% lower, while Pfizer (NYSE:PFE) stock ended 2016 about 2% higher than it began. . . .
Posted on 1/9/17
Celgene: A Core Biotech Holding For 2017 And Beyond
Newlan's Truism: An "acceptable" level of unemployment means that the government economist to whom it is acceptable still has a job.I get asked quite a bit . . .
Posted on 1/9/17
Will Johnson & Johnson Shock Investors with a Spin-off in 2017?
Every new year brings the possibility of surprise.Who would have thought that the Chicago Cubs would win the World Series at the beginning of 2016? Maybe . . .
Posted on 1/9/17
Why Biotech Titans Are Clashing Over Cholesterol
Amgen, Inc. (NASDAQ:AMGN) and Sanofi SA (NYSE:SNY) are locked in a heated patent battle, and a judge's decision to halt sales of Sanofi's cholesterol-lowering drug, Praluent, . . .
Posted on 1/9/17
American Media Announces Creation Of The AMI Fitness Group
American Media, Inc. (AMI) today announced the creation of the AMI Fitness Group, a new network that includes Men's Fitness, Muscle & Fitness, Muscle & Fitness . . .
Posted on 1/9/17
Lewis Drug and iMedicare Announce Partnership
NEW YORK--(BUSINESS WIRE)--iMedicare, the leading Medicare platform for community pharmacies, and Lewis Drug, the 45 store neighborhood pharmacy spanning across South Dakota, Iowa, and Minnesota, announced . . .
Posted on 1/6/17
Celldex Therapeutics, Inc.'s 3 Best Moves in 2016
Although a surprising trial failure made 2016 a punishing year for Celldex Therapeutics(NASDAQ:CLDX) investors, the beaten-up biotech took several wise steps that could set it up . . .
Posted on 1/6/17
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on January 3, 2017 it approved non-statutory stock options to purchase 4,000 shares of its common stock to . . .
Posted on 1/6/17
Bristol-Myers Squibb Announces Immunotherapy Clinical Collaboration with Janssen
NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) today announced a new clinical research collaboration with Janssen Biotech, Inc. to evaluate the combination of Bristol-Myers Squibb’s Immuno-Oncology (I-O) . . .
Posted on 1/5/17
Register By January 15 For The Valley Table’s Spring 2017 Hudson Valley Restaurant Week
Hudson Valley restaurants take note: join the more than 70 restaurants already participating in the The Valley Table’s Spring 2017 Hudson Valley Restaurant Week (HVRW) by . . .
Posted on 1/5/17
Did Biogen Just Throw in the Towel to Celgene?
IMAGE SOURCE: KB3TRAINING.COM Specialty medicines are only used by 1-2% of the U.S. population, but they're downright costly. In fact, in 2015 specialty drugs represented 37% . . .
Posted on 1/5/17
Blink Fitness Opens Its Newest Bronx Location In Gun Hill
Blink Fitness, the premium-quality, value-based fitness club, is excited to announce the grand opening ceremony of its newest Bronx location in Gun Hill. The club opened . . .
Posted on 1/5/17
Lewis Drug and iMedicare Announce Partnership to Begin Offering the iMedicare Platform in Its Locations
NEW YORK--(BUSINESS WIRE)--iMedicare, the leading Medicare platform for community pharmacies, and Lewis Drug, the 45 store neighborhood pharmacy spanning across South Dakota, Iowa, and Minnesota, announced . . .
Posted on 1/4/17
Soligenix Announces Extension of Development Agreement with Emergent BioSolutions
Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an . . .
Posted on 1/4/17
Interpace Diagnostics Announces Agreement with Blue Cross Blue Shield
Interpace Diagnostics Corp. (NASDAQ: IDXG), a company that provides clinically useful molecular diagnostic tests and pathology services for evaluating risks of cancer, announced today that the . . .
Posted on 1/4/17
Interpace Diagnostics Announces $4.2 Million Registered Direct Offering of Common Stock
Interpace Diagnostics Group, Inc. (NASDAQ: IDXG), a company that provides clinically useful molecular diagnostic tests
Posted on 1/3/17
Abeona Therapeutics Receives Orphan Drug Designation in The European Union for ABO-201 Gene Therapy Program in Juvenile Batten Disease
Abeona Therapeutics Inc., a New York City/Cleveland-based clinical-stage biopharmaceutical company focused on developing therapies for life-threatening rare genetic diseases, announced today that the European Medicines Agency . . .
Posted on 1/1/17
Interpace Diagnostics Group Announces 1-for-10 Reverse Split
Interpace Diagnostics Group, Inc. (NASDAQ: IDXG), a company that provides clinically useful molecular diagnostic tests and pathology services for evaluating risks of cancer, announced today that . . .
Posted on 12/27/16
Rasna Therapeutics Closes Private Placement of $2 Million
NEW YORK--(BUSINESS WIRE)--Rasna Therapeutics, Inc. (OTCQB:RASP), a development stage biotechnology company focused on the development of cancer drugs, today announced that it has closed a private . . .
Posted on 12/23/16
TSO3 Enters into Strategic Partner Facility Agreement with The Mount Sinai Hospital
TSO3 Inc. (TSX: TOS), an innovator in sterilization technology for medical devices in healthcare settings, has entered into a strategic partner facility agreement with The Mount . . .
New York
